Table 1.
Model | Figure | Purpose | Analogous wound-healing process | Cell types used | References |
---|---|---|---|---|---|
Sprouting | Figure 2 | To test the ability of fibroblasts to induce an angiogenic-like response in endothelial cells | Angiogenesis | HUVEC, DFUF/DFF/NFF | 10,24,25 |
Human skin equivalent tissue | Figure 3 | To examine the cross-talk between fibroblasts and keratinocytes in a skin-like tissue | Fibroblast-keratinocyte communication | NHKs, DFUF/DFF/NFF | 2,11 |
Re-epithelialization | Figure 4, Supplementary Figure S1 | To determine the ability of fibroblasts to support wound re-epithelialization | Re-epithelialization | NHKs, HFFs, DFUF/DFF/NFF | 12,28,29 |
Self-assembled ECM | Figure 5 | To evaluate fibroblast capacity to synthesize and assemble ECM de novo | Granulation tissue production | DFUF/DFF/NFF | 7,8 |
DFFs, type ii diabetic, nonulcerated foot-derived fibroblasts; DFUFs, type II diabetic foot ulcer-derived fibroblasts; ECM, extracellular matrix; HFF, human foreskin fibroblast; HUVEC, human umbilical vein endothelial cell; nondiabetic, NFF, nonulcerated foot-derived fibroblasts; NHKs, normal human keratinocytes.